Topical Protease Therapy as a Novel Method of Epidermal Ablation: Preliminary Report

doi:10.1111/j.1524-4725.2005.31034

If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.

It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.

Wiley InterScience

Dermatologic Surgery

Volume 31 Issue 2, Pages 139 - 148

Published Online: 21 Mar 2006

View all previous titles for this journal

Published on behalf of

Go to ASDS

< Previous Abstract | Next Abstract >

Save Article to My Profile Download Citation Request Permissions

Abstract | References | Full Text: HTML, PDF (Size: 1022K) | Related Articles | Citation Tracking

Topical Protease Therapy as a Novel Method of Epidermal Ablation: Preliminary Report

Fein Howard, MD*, Maytin Edward V., MD, PhD†, Mutasim Diya F., MD‡ Bailin Philip L., MD§

*Palos Verdes Dermatology Associates, Rolling Hills Estates, California, and Division of Dermatology, Harbor-UCLA Medical Center, Torrance, California †Department of Dermatology, The Cleveland Clinic Foundation, Cleveland, Ohio ‡Department of Dermatology, University of Cincinnati, Cincinnati, Ohio §Department of Dermatology, The Cleveland Clinic Foundation, Cleveland, Ohio

Address correspondence and reprint requests to: Howard Fein, MD, Palos Verdes Dermatology Associates, Inc., 550 Deep Valley Drive, Suite 287, Rolling Hills Estates, CA 90274; or e-mail: hfein@pvdermatology.com.

ABSTRACT

BackgroundFor more than 50 years, proteolytic enzymes have been extensively used in laboratory settings for the purposes of in vitro epidermal separation and keratinocyte isolation. However, the topical, in vivo pharmacologic properties of these enzymes are virtually unknown. Previous therapeutic applications for topically applied proteases have been limited to wound débridement.

ObjectiveTo characterize the clinical and histologic effects of topically applied proteases as a method of therapeutic epidermal ablation.

Materials and methodsSKH-1 hairless mouse and human skin samples were exposed both in vitro and in vivo to varying concentrations of the proteases subtilisin, trypsin, and dispase for different exposure durations. The effects of protease exposure were then assessed by both clinical and histologic examination.

ResultsExposure of both human and mouse skin samples to topical protease solutions resulted in reproducible, differential patterns of epidermal ablation: subcorneal, intraepidermal, and subepidermal. In a limited study, topical application of trypsin solution resulted in the scar-free ablation of lesions of seborrheic keratosis located on the lower extremity.

ConclusionTopically applied proteases represent an alternative method of epidermal ablation with several potential advantages over existing techniques. Further studies are needed to delineate ideal enzyme formulations, vehicles, and applications.

HOWARD FEIN, MD, HAS A PENDING US PATENT APPLICATION CONCERNING THE DERMATOLOGIC APPLICATIONS OF TOPICAL PROTEASE THERAPY.

DIGITAL OBJECT IDENTIFIER (DOI)

10.1111/j.1524-4725.2005.31034 About DOI